Skip to content
Screener

CG Oncology CGON Price / sales

Price / sales at other companies

Pfizer logo
PfizerPFE
2.2×0.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.2×+2.2×
Gilead Sciences logo
Gilead SciencesGILD
5.2×+0.5×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
56.2×-26.1×
UroGen Pharma logo
UroGen PharmaURGN
9.5×+2.8×
Immunome logo
ImmunomeIMNM
616.2×+563×

Other financials

Income statement

See full
Revenue$1.2M—
Operating income-$86.4M-77.3%
Net income-$79.1M-90.8%
EPS (diluted)-$0.90-66.7%

Balance sheet

See full
Cash & equivalents$19.6M+34.3%
Total debt$8.8M+787%
Total equity$1.0B+53.5%
Total assets$1.1B+54.8%

Cash flow

See full
Operating cash flow-$46.4M-66.0%
CapEx$468.0K+3,243%
Free cash flow-$46.9M-67.6%

Valuation

See full
Market cap$6.6B+242%
Enterprise value$6.59B+244%

Profitability

See full
Operating margin-4,056.2%-1,873pp
Net margin-3,602.7%-1,650pp
FCF margin-2,879.6%-1,307pp

Returns & leverage

See full
Return on equity-26.4%+9.3pp
Debt / equity0×0.0×
Current ratio22.2×+0.1×

Where this comes from

Calculated from CG Oncology’s reported figures.

market cap/total revenue=1,006.2×

Based on the most recent quarter.

The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336918

FAQ

What is CG Oncology's price / sales?
CG Oncology (CGON) reported price / sales of 1,006.2× in Q2 2026.
How has CG Oncology's price / sales changed year-over-year?
CG Oncology's price / sales decreased by 71.8% year-over-year, from 3,569.2× to 1,006.2×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about CG Oncology's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude